CLINICAL_TRIALS
trial_result
· 2018-07-05
Clinical Trial Update: Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors [Phase 1]
Summary
A Phase 1 trial of satraplatin in children and young adults with refractory solid tumors, including brain tumors, has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Solid Tumors, Brain Tumors | Phase 1 | Status: COMPLETED